Reposted from SARCOMA@LISTSERV.ACOR.ORG
Subject: [SARCOMA] Do you know any Young Adult ages 18-39? with Cancer in Need of
Adventure Therapy?
lisa@firstdescents.org
If so, please read on about First Descents!! We have 15 week long programs
running from April to September and we need your help in finding
participants!!
First Descents programs are all about having fun, getting outside, and
pushing your limits through kayaking, rock climbing and other outdoor
activities. Our camps are structured and designed with you in mind. There's
no need to have kayaking or climbing experience. We know your body has been
through a lot - we don't have any requirements for fitness. We encourage you
to challenge yourself, but won't push you past your capabilities. Our
programs are free to all who are accepted. All you need to bring is what
you'd typically pack for a trip. First Descents has all the gear and
necessary equipment to keep you safe, warm and relatively dry. We'll provide
everything you need and teach you the skills, you just show up! Your week at
camp will be full of activity but you'll have plenty of time to relax too.
When we're not on the river or climbing, we hang out, hike, play volleyball,
listen to music, etc. You'll get to know the other participants well!
Thanks in advance for your help. If you have any questions feel free to
email or call me. See at the firstdescents.org about the FD program and
perfect participant. Please forward this email on to anyone you think may
benefit from this amazing experience.
First Descents programs in US for young adults ages 18-39
Though probably have no effect on disease progression, can have a significant effect on the overall well-being of the patient
Return to “Diet and lifestyle”
Jump to
- Welcome to CureASPS.org!
- ↳ Guest Book
- ↳ Forum Issues and Suggestions
- News and Updates
- ↳ Personal Stories and Updates
- ↳ Success Stories
- ↳ Rest In Peace
- ↳ Anonymous Patient Updates
- ↳ Chinese group news
- ↳ Medical Publications
- ↳ Other Publications
- ↳ Sarcoma Meetings and Conferences
- ASPS Clinical Trials
- ↳ Other Clinical Trials
- ↳ COMPLETED - ARQ 197 Clinical Trial
- ↳ COMPLETED - Dana Farber Vaccine Clinical Trial (GVAX)
- ↳ Dasatinib
- ↳ Alisertib
- ↳ Cediranib
- ↳ Anlotinib
- ↳ Immune checkpoint inhibitors (ICI)
- ↳ Axitinib and Pembrolizumab (Keytruda) in Miami, US
- ↳ TECENTRIQ (atezolizumab) by Genentech
- ↳ Pfizer's PF-06801591
- ↳ Durvalumab+Tremelimumab at MDACC
- Symptoms and Diagnostics
- ↳ Symptoms
- ↳ Scan Types and Follow-Up
- ↳ Molecular Studies
- ↳ Pathology results
- Primary Tumor Treatment
- ↳ Resection
- ↳ Treatment of Non-Resectable Primary Tumor
- ↳ Radiation
- Systemic Treatment
- ↳ TKI
- ↳ Sutent (sunitinib)
- ↳ Pazopanib
- ↳ Сabozantinib (Cometriq)
- ↳ Sorafenib
- ↳ Chemotherapy
- ↳ Metronomic chemotherapy
- ↳ Temozolomide (Temodar)
- ↳ Side effects of systemic treatments
- ↳ Interferon alpha
- ↳ Immune checkpoint inhibitors ICI (PD-1 and PD-L1 targeting drugs)
- ↳ Keytruda
- ↳ Opdivo
- ↳ TECENTRIQ (atezolizumab)
- ↳ Toxicity, problems and potentiation strategies
- ↳ Treatment response criteria and evaluation/scanning problems/rare cases
- ↳ treatment discontinuation/re-treatment
- Metastatic Disease Treatment
- ↳ Local treatment modalities
- ↳ cryoablation
- ↳ Side effects/complications of the local ablations
- ↳ Radiosurgery
- ↳ Microwave ablation
- ↳ High intensity focused ultrasound (HIFU)
- ↳ Lung Metastases
- ↳ Laser assisted surgery
- ↳ Brain Metastases
- ↳ Bone Metastases
- ↳ Other Metastases
- ↳ Abdominal Metastases
- ↳ Liver metastases
- ↳ Heart Metastases
- ↳ Spinal metastases
- ↳ Adrenal metastases
- ↳ Pancreatic metastases
- Living with ASPS
- ↳ Insurance Coverage
- ↳ Second opinion from a sarcoma center
- ↳ Finanical assistance
- ↳ Diet and lifestyle
- ↳ Related studies
- ↳ Pain management
- ↳ Travel assistance